OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Molecular Medicine is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Advisory Board and Contents	246
Subscription and Copyright Information	239
Advisory Board and Contents	211
Subscription and Copyright Information	188
Advisory Board and Contents	180
Microbiota: a dawn for cancer metastasis therapy	168
Consideration of the importance of measuring thermal discomfort in biomedical research	148
The right drug at the right time: key to IBD success	133
Fc-optimized checkpoint antibodies for cancer immunotherapy	121
Subscription and Copyright Information	117
Subscription and Copyright Information	115
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates	112
Subscription and Copyright Information	107
Bursts of brain erosion: seizures and age-dependent neurological vulnerability	105
Neutrophils and extracellular traps in crystal-associated diseases	99
Opportunities and challenges for biomarker discovery using electronic health record data	97
Cellular senescence in neuroinflammatory disease: new therapies for old cells?	89
Lymph node microenvironment rewires ferroptosis redox defenses	88
Beneath the radar: immune-evasive cell sources for stroke therapy	81
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes	80
m6A and beyond: RNA modifications shaping angiogenesis	78
Pushing the boundaries of brain organoids to study Alzheimer’s disease	77
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models	76
d-Amino acids: new clinical pathways for brain diseases	76
Microbes and mood: innovative biomarker approaches in depression	75

Advisory Board and Contents	72
Brain-specific regulatory T cell expansion limits cognitive decline	70
Subscription and Copyright Information	70
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers	69
iPSCs and DRGs: stepping stones to new pain therapies	69
Insights from HIV-1 vaccine and passive immunization efficacy trials	67
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients	63
Molecular mechanisms in the pathogenesis of dengue infections	62
Amyloid and collagen templates in aortic valve calcification	61
Hormesis as an adaptive response to infection	57
Keratinocytes: new perspectives in inflammatory skin diseases	56
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality	56
Acquired resistance to immunotherapy in solid tumors	53
Epigenetic regulation in intervertebral disc degeneration	51
RNA immunotherapy: revolutionizing cancer and autoimmune disease treatments	51
Emerging roles of cyclin-dependent kinase 7 in health and diseases	50
Erythropoietic protoporphyrias: updates and advances	50
Significant challenges to translating breakthrough science in Mexico	49
Engineering cytokines for tumor-targeting and selective T cell activation	49
Three ‘E’ challenges for siRNA drug development	49
The endoplasmic reticulum proteostasis network and bone disease	48
Antibody signatures in inflammatory bowel disease: current developments and future applications	46